CompletedNot applicableNCT06328621

Lung Cancer Risk Assessment and Etiology

This study examines the biological and social determinants that may increase the risk for lung cancer in patients and never-smoking individuals. Biological characteristics of a person can include their genetics and social determinants of a person can include their education, income, and environment, all of which can impact their health. Information collected in this study may help increase early detection of lung cancer.

Checked against the public recordLast updated Mar 18, 2026 · Source: ClinicalTrials.gov

StatusCompleted
PhaseNot applicable
U.S. locations1
SponsorCity of Hope Medical Center
01
Study overview

What this study is about

Purpose
Not specified
Study type
Observational
Phase
Not applicable
Sponsor
City of Hope Medical Center
Interventions being studied
Procedure: Biospecimen Collection; Procedure: Computed Tomography; Other: Electronic Health Record Review; Other: Survey Administration
02
Explore related studies

How this study is categorized

These labels come from structured fields and exact terms in the public record.

03
Public criteria

Who may be able to participate

Inclusion Criteria: * Have had clinical germline genetic testing and/or have consented or expressed a willingness to consent to the City of Hope (COH) General Research Protocol COH IRB # 07047 * Age \>= 18 years * Willing to have about 30 mL of blood (approximately 2 tablespoons) drawn during the aspiration visit * Speak English, Spanish, or Mandarin * Lung cancer patients: meeting at least one of the following criteria: * Be a never-smoker with lung cancer (excludes atypical/typical carcinoid and small cell tumors) * Be diagnosed with lung cancer =\< 50 years of age * Have a germline alteration known/suspected to be associated with elevated lung cancer risk * Have a strong family history of lung cancer (\>= one first, second or third degree relative with never-smoking lung cancer, \>= three first, second or third degree relative with lung cancer in one lineage \[side of the family\], \>= one first, second or third degree relative diagnosed with lung cancer under the age of 50. Patients may also be considered eligible if they meet the family history criteria in part and have a truncated family structure \[e.g., only one first and one second degree relative with lung cancer in a small family\]) * Unaffected patients (i.e., those without a lung cancer diagnosis and other cancer diagnosis for the past 5 years) who are at least 50 years of age or at most age 10 years younger than the first case of lung cancer in the family, meeting at least one of the following criteria: * Have a germline alteration known/suspected to be associated with elevated lung cancer risk * Have a strong family history of lung cancer (\>= one first, second or third degree relative with never-smoking lung cancer, \>= three first, second or third degree relative with lung cancer in one lineage \[side of the family\], \>= one first, second or third degree relative diagnosed with lung cancer under the age of 50. Patients may also be considered eligible if they meet the family history criteria in part and have a truncated family structure \[e.g., only one first and one second degree relative with lung cancer in a small family\]) * Of East Asian descent with any family history of lung cancer * Documented informed consent of the participant Exclusion Criteria: * Unable to provide informed consent * Patients who fall under the unaffected cohort criteria but received chest imaging (except chest x-ray) within the last year

Important: This is the sponsor’s public criteria, not a determination of eligibility. The study team must review your individual situation.

04
Study sites

U.S. locations

  • City of Hope Medical CenterDuarte, California

Source and freshness
Processed from ClinicalTrials.gov. Last public update: Mar 18, 2026. Always confirm current availability with the study team.

View original record ↗